- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 25, 2025 | 224.8M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $20.55M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $22.3M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $286.56M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $233.32M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $2.47B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $2.47B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $266.63M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $252.69M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $303.13M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $288.72M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.09B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.04B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.78B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.76B |
| Total Assets | Q1 2025 · Mar 31, 2024 | $2.71B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 228.41M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $41.22M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $27.77M |
| Capex | Q1 2025 · Mar 31, 2024 | $31.87M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $129.88M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.47 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.47 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $30.71M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $42.18M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $129.35M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $202.24M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $387.99M |
| Revenue | Q1 2025 · Mar 31, 2024 | $590.23M |